The oral commensal, Streptococcus gordonii, synergizes with Tat protein to induce HIV-1 promoter activation in monocytes/macrophages

Cellular Immunology

Volumn 269, Issue 1, 2011, Pages 38-45

  González, Octavio A ^a   Ebersole, Jeffrey L ^a   Huang, Chifu B ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF DENTISTRY   (United States)

Author keywords

HIV 1; Monocytes macrophages; Oral bacteria; Periodontitis; S. gordonii; Transcriptional Trans activator

Indexed keywords

I KAPPA B; INTERLEUKIN 6; INTERLEUKIN 8; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL STRAIN; CELL CULTURE; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; GENE ACTIVATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS GORDONII; VIRUS REPLICATION;

CELL LINE; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MONOCYTES; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; STREPTOCOCCUS GORDONII; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

FUSOBACTERIUM NUCLEATUM; HUMAN IMMUNODEFICIENCY VIRUS 1; STREPTOCOCCUS GORDONII; STREPTOCOCCUS SANGUINIS;

EID: 79955479436     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.03.008     Document Type: Article

References (47)

1. Alexaki A., Liu Y., Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr. HIV Res. 2008, 6:388-400.
2. Coleman C.M., Wu L. HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 2009, 6:51.
3. Richman D.D., Margolis D.M., Delaney M., Greene W.C., Hazuda D., Pomerantz R.J. The challenge of finding a cure for HIV infection. Science 2009, 323:1304-1307.
4. Pereira L.A., Bentley K., Peeters A., Churchill M.J., Deacon N.J. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 2000, 28:663-668.
5. Rohr O., Marban C., Aunis D., Schaeffer E. Regulation of HIV-1 gene transcription: from lymphocytes to microglial cells. J. Leukoc. Biol. 2003, 74:736-749.
6. Huigen M.C., Kamp W., Nottet H.S. Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur. J. Clin. Invest. 2004, 34:57-66.
7. Brady J. Tat gets the " green" light on transcription initiation. Retrovirology 2005, 2:69.
8. Chang H.C., Samaniego F., Nair B.C., Buonaguro L., Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997, 11:1421-1431.
9. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 1993, 67:277-287.
10. Xiao H., Neuveut C., Tiffany H.L., Benkirane M., Rich E.A., Murphy P.M., Jeang K.T. Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl. Acad. Sci. USA 2000, 97:11466-11471.
11. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995, 375:497-500.
12. Vogel B.E., Lee S.J., Hildebrand A., Craig W., Pierschbacher M.D., Wong-Staal F., Ruoslahti E. A novel integrin specificity exemplified by binding of the alpha v beta 5 integrin to the basic domain of the HIV Tat protein and vitronectin. J. Cell Biol. 1993, 121:461-468.
13. Mitola S., Sozzani S., Luini W., Primo L., Borsatti A., Weich H., Bussolino F. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood 1997, 90:1365-1372.
14. Contreras X., Bennasser Y., Chazal N., Moreau M., Leclerc C., Tkaczuk J., Bahraoui E. Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production. Virology 2005, 332:316-328.
15. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55:1189-1193.
16. Chang H.K., Gallo R.C., Ensoli B. Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J. Biomed. Sci. 1995, 2:189-202.
17. Huang C.B., Emerson K.A., Gonzalez O.A., Ebersole J.L. Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells. Oral Microbiol. Immunol. 2009, 24:401-407.
18. Gonzalez O.A., Li M., Ebersole J.L., Huang C.B. HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages. Clin. Vaccine Immunol. 2010, 17:1417-1427.
19. Han Y.W., Redline R.W., Li M., Yin L., Hill G.B., McCormick T.S. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect. Immun. 2004, 72:2272-2279.
20. Kesavalu L., Holt S.C., Ebersole J.L. In vitro environmental regulation of Porphyromonas gingivalis growth and virulence. Oral Microbiol. Immunol. 2003, 18:226-233.
21. Ji S., Hyun J., Park E., Lee B.L., Kim K.K., Choi Y. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J. Periodontal. Res. 2007, 42:410-419.
22. Gonzalez O.A., Ebersole J.L., Huang C.B. Supernatants from oral epithelial cells and gingival fibroblasts modulate human immunodeficiency virus type 1 promoter activation induced by periodontopathogens in monocytes/macrophages. Mol. Oral Microbiol. 2010, 25:136-149.
23. Felber B.K., Pavlakis G.N. A quantitative bioassay for HIV-1 based on trans-activation, Science. Science 1988, 239:184-187.
24. Kutsch O., Benveniste E.N., Shaw G.M., Levy D.N. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 2002, 76:8776-8786.
25. Bohan C.A., Kashanchi F., Ensoli B., Buonaguro L., Boris-Lawrie K.A., Brady J.N. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. Gene Expr. 1992, 2:391-407.
26. Mahieux R., Lambert P.F., Agbottah E., Halanski M.A., Deng L., Kashanchi F., Brady J.N. Cell cycle regulation of human interleukin-8 gene expression by the human immunodeficiency virus type 1 Tat protein. J. Virol. 2001, 75:1736-1743.
27. Okamoto S., Mukaida N., Yasumoto K., Horiguchi H., Matsushima K. Molecular mechanism of interleukin-8 gene expression. Adv. Exp. Med. Biol. 1993, 351:87-97.
28. Sonoda Y., Kasahara T., Yamaguchi Y., Kuno K., Matsushima K., Mukaida N. Stimulation of interleukin-8 production by okadaic acid and vanadate in a human promyelocyte cell line, an HL-60 subline. Possible role of mitogen-activated protein kinase on the okadaic acid-induced NF-kappaB activation. J. Biol. Chem. 1997, 272:15366-15372.
29. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B.R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J.N., Hecht F.M., Picker L.J., Lederman M.M., Deeks S.G., Douek D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365-1371.
30. Jiang W., Lederman M.M., Hunt P., Sieg S.F., Haley K., Rodriguez B., Landay A., Martin J., Sinclair E., Asher A.I., Deeks S.G., Douek D.C., Brenchley J.M. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 2009, 199:1177-1185.
31. Nordone S.K., Ignacio G.A., Su L., Sempowski G.D., Golenbock D.T., Li L., Dean G.A. Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation. AIDS Res. Hum. Retroviruses 2007, 23:1387-1395.
32. Mayer M.L., Phillips C.M., Townsend R.A., Halperin S.A., Lee S.F. Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordonii. Scand. J. Immunol. 2009, 69:351-356.
33. Ciabattini A., Cuppone A.M., Pulimeno R., Iannelli F., Pozzi G., Medaglini D. Stimulation of human monocytes with the gram-positive vaccine vector Streptococcus gordonii. Clin. Vaccine Immunol. 2006, 13:1037-1043.
34. Devadas K., Hardegen N.J., Wahl L.M., Hewlett I.K., Clouse K.A., Yamada K.M., Dhawan S. Mechanisms for macrophage-mediated HIV-1 induction. J. Immunol. 2004, 173:6735-6744.
35. Lafrenie R.M., Wahl L.M., Epstein J.S., Yamada K.M., Dhawan S. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J. Immunol. 1997, 159:4077-4083.
36. Nath A., Conant K., Chen P., Scott C., Major E.O. Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J. Biol. Chem. 1999, 274:17098-17102.
37. Leghmari K., Bennasser Y., Bahraoui E. HIV-1 Tat protein induces IL-10 production in monocytes by classical and alternative NF-kappaB pathways. Eur. J. Cell Biol. 2008, 87:947-962.
38. Ott M., Lovett J.L., Mueller L., Verdin E. Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors. J. Immunol. 1998, 160:2872-2880.
39. Chan K.G., Mayer M., Davis E.M., Halperin S.A., Lin T.J., Lee S.F. Role of D-alanylation of Streptococcus gordonii lipoteichoic acid in innate and adaptive immunity. Infect. Immun. 2007, 75:3033-3042.
40. Carmody R.J., Chen Y.H. Nuclear factor-kappaB: activation and regulation during toll-like receptor signaling. Cell Mol, Immunol. 2007, 4:31-41.
41. Mukaida N., Shiroo M., Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J. Immunol. 1989, 143:1366-1371.
42. Williams S.A., Kwon H., Chen L.F., Greene W.C. Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1. J. Virol. 2007, 81:6043-6056.
43. Bode K.A., Schmitz F., Vargas L., Heeg K., Dalpke A.H. Kinetic of RelA activation controls magnitude of TLR-mediated IL-12p40 induction. J. Immunol. 2009, 182:2176-2184.
44. Chun R.F., Semmes O.J., Neuveut C., Jeang K.T. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 1998, 72:2615-2629.
45. Nicol M.Q., Mathys J.M., Pereira A., Ollington K., Ieong M.H., Skolnik P.R. Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells. J. Virol. 2008, 82:7790-7798.
46. Di Fabio S., Medaglini D., Rush C.M., Corrias F., Panzini G.L., Pace M., Verani P., Pozzi G., Titti F. Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens. Vaccine 1998, 16:485-492.
47. Oggioni M.R., Medaglini D., Romano L., Peruzzi F., Maggi T., Lozzi L., Bracci L., Zazzi M., Manca F., Valensin P.E., Pozzi G. Antigenicity and immunogenicity of the V3 domain of HIV type 1 glycoprotein 120 expressed on the surface of Streptococcus gordonii. AIDS Res. Hum. Retroviruses 1999, 15:451-459.